Lipid-Drug-Conjugate (LDC) Nanoparticles as Novel Carrier System for the Hydrophilic Antitrypanosomal Drug Diminazenediaceturate

Abstract

The objective of the present study was to incorporate the hydrophilic drug diminazenediaceturate at a high loading into lipid nanoparticles by creating nanoparticles from lipid-drug conjugates (LDC). IR and DSC data showed that the antitrypanosomal drug diminazene is able to react with fatty acids to form water-insoluble salts like diminazenedistearate and -dioleate. The salts could be transformed into nanoparticles using high-pressure homogenization technique, established for solid lipid nanoparticles (SLN). By using polysorbate 80 as surfactant, physically stable LDC nanoparticle dispersions of both salts could be obtained. The mean PCS diameters and polydispersity indices were 364 nm and 0.233 for diminazenedistearate and 442 nm and 0.268 for diminazenedioleate, respectively. Due to the composition of the LDC bulk materials, nanoparticles with a high drug load of 33% (w/w) were obtained even for this highly water-soluble drug diminazenediaceturate. The new carrier system of LDC nanoparticles overcomes one limitation of SLN, i.e. the limited loading capacity for hydrophilic drugs. Transforming water-soluble hydrophilic drugs into LDC and formation of nanoparticles allows prolonged drug release and targeting to specific sites by i.v. injection. These results provide a first basis of using LDC-polysorbate 80 nanoparticles for brain delivery of diminazene to treat second stage human African trypanosomiasis (HAT).

Nanoemulsion loaded with lycobetaine–oleic acid ionic complex: physicochemical characteristics, in vitro, in vivo evaluation, and antitumor activity

“…The codissolve-evaporation method can be used to prepare LBT-OA. 20,21 Briefly, LBT-OA was prepared by dissolving 10 mg of LBT base and 25 mg of OA in dichloromethane, followed by solvent evaporation at 30°C under reduced pressure. Compared with the codissolve-evaporation method, the stirring method avoided using a toxic organic solvent, and the process was more convenient.…”

Revolutionary Impact of Nanodrug Delivery on Neuroscience

“…Although all three of the basic nanotechnology applications can also contribute to an understanding of neuropathophysiology, however, for the most part, applications of nanotechnology in clinical neuroscience primarily concern themselves with limiting and reversing neuropathological disease states. Generally, the clinical applications of nanotechnology in neuroscience include (a) nanotechnology approaches designed to support and/or promote the functional regeneration of the nervous system [202]; (b) neuroprotective strategies, in particular those that use fullerene derivatives [203-206]; and (c) nanotechnology approaches that facilitate the delivery of drugs and small molecules across the BBB [207-212]. One of the frontiers of neuropharmacotherapy is the delivery of drugs to the central nervous system (CNS) with a high degree of specificity and enough concentration.…”

Solid Lipid Nanoparticles as Efficient Drug and Gene Delivery Systems: Recent Breakthroughs

“…The particle size has not been influenced by higher stirring rates, but slightly improved the polydispersity index. 15,16 Hot homogenization Hot homogenization method is performed at higher temperature than the melting point of the lipid and it is similar to homogenization of emulsion. It can be performed by both high pressure homogenizers and high intensity ultrasound.…”